Format

Send to

Choose Destination
J Drugs Dermatol. 2006 Sep;5(8):796-8.

A novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy.

Author information

1
Gold Skin Care Center, Nashville, TN 37215, USA. goldskin@goldskincare.com

Abstract

BACKGROUND AND OBJECTIVES:

Photodynamic therapy (PDT) with topical 5-aminolevulinic acid (ALA) is becoming a more popular dermatologic procedure. Newer protocols have virtually eliminated any associated untoward effects. Phototoxicity, although rare, can still occur and requires aggressive post-therapy care. Recently, a new biorestorative skin care cream, containing human growth factors and cytokines, was used to treat 2 severe cases of PDT-associated phototoxicity.

MATERIALS AND METHODS:

This paper describes 2 case reports of severe phototoxicity following ALA-PDT treatments. The novel skin care cream was utilized in both cases phototoxicity.

RESULTS:

Complete resolution of the phototoxic reaction was seen, leaving both patients with normal skin texture and tone.

CONCLUSIONS:

This novel skin care cream may prove useful in wound healing following treatment with lasers and light sources or dermatologic surgery.

PMID:
16989195
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center